Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 13/20 | 0.68 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | APEX1 | P27695 | 1/20 | 0.41 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | SLCO2B1 | O94956 | 1/20 | 0.39 |
| ▸ | TNF | P01375 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | CASP1 | P29466 | 2/20 | 0.39 |
| ▸ | CASP7 | P55210 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Beta-D-Glucose SCHEMBL3018938 | 1.00 | APP (0.68) | APPCYP1A2KDM4EALDH1A1MEN1 | |
| D-Galactose SCHEMBL15391861 | 1.00 | APP (0.68) | APPCYP1A2KDM4EALDH1A1MEN1 | |
| Beta-D-Glucose SCHEMBL383291 | 0.87 | SLC5A2 (0.49) | APPCYP1A2KDM4EALDH1A1MEN1 | |
| B-D-Galactose SCHEMBL1712843 | 0.87 | SLC5A2 (0.49) | APPCYP1A2KDM4EALDH1A1MEN1 | |
| D-Galactose SCHEMBL2370315 | 0.87 | SLC5A2 (0.49) | APPCYP1A2KDM4EALDH1A1MEN1 | |
| Dextrose SCHEMBL5679244 | 0.87 | SLC5A2 (0.49) | APPCYP1A2KDM4EALDH1A1MEN1 | |
| B-D-Galactose SCHEMBL8515088 | 0.87 | SLC5A2 (0.49) | APPCYP1A2KDM4EALDH1A1MEN1 | |
| B-D-Galactose SCHEMBL307802 | 0.87 | SLC5A2 (0.49) | APPCYP1A2KDM4EALDH1A1MEN1 | |
| SCHEMBL8066 | 0.82 | APP (1.00) | APPCYP1A2MEN1KMT2APOLB | |
| Alcohol SCHEMBL6810203 | 0.81 | APP (0.86) | APPCYP1A2MEN1KMT2APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 635 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119147760-A | Single-molecule immunity detection method based on enzymatic reaction | 深圳栅极芯致生物科技有限公司 | 2024-12-17 | — | — | CN | claimed |
| CN-117761313-A | Single-molecule immunity detection method based on enzymatic reaction | 深圳栅极芯致生物科技有限公司 | 2024-03-26 | — | — | CN | claimed |
| US-20230035402-A1 | MISFOLDED SOD1 ASSAY | AL-S PHARMA AG (CH) | 2023-02-02 | — | — | US | claimed |
| US-20220187322-A1 | USE OF A PS396 ASSAY TO DIAGNOSE TAUOPHATIES | H. LUNDBECK A/S (DK) | 2022-06-16 | — | — | US | claimed |
| EP-3948295-A1 | USE OF A PS396 ASSAY TO DIAGNOSE TAUOPHATIES | H. Lundbeck A/S (DK) | 2022-02-09 | — | — | EP | claimed |
| CN-113748343-A | Use of the pS396 assay for diagnosing TAU proteinopathies | H.隆德贝克有限公司 | 2021-12-03 | — | — | CN | claimed |
| US-20210025890-A1 | METHODS FOR DETECTING AND QUANTIFYING FGF21 | GENENTECH, INC. (US) | 2021-01-28 | — | — | US | claimed |
| WO-2020193500-A1 | USE OF A PS396 ASSAY TO DIAGNOSE TAUOPHATIES | H. LUNDBECK A/S (DK) | 2020-10-01 | — | — | WO | claimed |
| US-10287620-B2 | Digital polymerase fidelity assay | BIO-RAD LABORATORIES, INC. (US) | 2019-05-14 | — | — | US | claimed |
| US-20170314060-A1 | DIGITAL POLYMERASE FIDELITY ASSAY | BIO-RAD LABORATORIES, INC | 2017-11-02 | — | — | US | claimed |
| EP-1654372-A2 | MEMBRANE TRANSPORTABLE FLUORESCENT SUBSTRATES | Applera Corporation (US) | 2006-05-10 | — | — | EP | claimed |
| US-20050244907-A1 | Methods, compositions, and kits for analysis of enzyme activity in cells | APPLERA CORPORATION | 2005-11-03 | — | — | US | claimed |
| US-6933126-B2 | Membrane transportable fluorescent substrates | APPLERA CORPORATION (US) | 2005-08-23 | — | — | US | claimed |
| WO-2005059163-A2 | METHODS, COMPOSITIONS, AND KITS FOR ANALYSIS OF ENZYME ACTIVITY IN CELLS | APPLERA CORPORATION (US) | 2005-06-30 | — | — | WO | claimed |
| US-20040203088-A1 | Method of monitoring biofouling in membrane separation systems | NALCO COMPANY | 2004-10-14 | — | — | US | claimed |
| US-20040115757-A1 | Method of monitoring biofouling in membrane separation systems | NALCO COMPANY | 2004-06-17 | — | — | US | claimed |
| US-6699684-B2 | BASED ON THE CHANGE IN THE SIGNAL OF A FLUOROGENIC AGENT WHICH REACTS WITH MICROORGANISM | NALCO COMPANY | 2004-03-02 | — | — | US | claimed |
| US-20040018583-A1 | METHOD OF MONITORING BIOFOULING IN MEMBRANE SEPARATION SYSTEMS | ECOLAB USA INC. | 2004-01-29 | — | — | US | claimed |
| US-20030103902-A1 | Membrane transportable fluorescent substrates | APPLIED BIOSYSTEMS, INC. | 2003-06-05 | — | — | US | claimed |
| WO-2003025192-A2 | MEMBRANE TRANSPORTABLE FLUORESCENT SUBSTRATES | PE CORPORATION (NY) (US) | 2003-03-27 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030103902-A1 | Membrane transportable fluorescent substrates | SLC47A1, SLC47A2, SLC75A1 | APP 3313/4885CYP1A2 2864/4885KDM4E 4840/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.